◼ Archived
World
Roche’s changing plans show how MFN is complicating European drug launches
6 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Roche
18 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Roche Targets Emerging Oncology Market With New Lung-Cancer Drug
Roche's new lung-cancer drug divarasib shows superior survival rates compared to rivals in late-stage trials, targeting the emerging oncology market.
◼ Archived
Business
Roche builds blockbuster BTK case for fenebrutinib in multiple sclerosis as FDA decision approaches
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Roche returns to China’s Hansoh for $15B biobucks ADC pact
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Sports
Dutch cycling team to investigate claims that ‘traumatised’ riders feel ‘unsafe’: ‘I thought about harming myself’
Team Picnic-PostNL faces an independent investigation following extensive reports detailing a toxic culture of fear.
◼ Archived
Business
Roche inks $1.2B deal with China's Rona to enter emerging ALK7 obesity race
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Genentech pays Alector $100M for preclinical Parkinson’s prospect
Genentech has entered a global license agreement with Alector for a preclinical brain-penetrant enzyme replacement therapy targeting Parkinson's disease.
◼ Archived
Business
Roche Halts Development of Obesity Drug Candidate
Roche has halted the development of emugrobart, a muscle-preserving obesity drug candidate, following a failed interim analysis.
◼ Archived
Business
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
Roche's experimental drug sefaxersen meets its primary endpoint in a late-stage study for the autoimmune disease IgAN.
◼ Archived
Business
Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody
Roche has secured a global licensing pact with Simcere Zaiming for an experimental B-cell-targeting antibody.
◼ Archived
Business
🔮 fades ✓
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
BioNTech and Genentech have terminated a phase 2 mRNA colorectal cancer vaccine trial after safety reviews revealed more deaths than in the control group.
◼ Archived
Business
🔮 fades ✓
Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly
The FDA has granted clearance to a first-of-its-kind blood test for Alzheimer's biomarkers developed through a partnership between Roche and Eli Lilly.
◼ Archived
Health
🔮 fades ✗
Blood Tests to Predict Alzheimer’s Are Causing Confusion and Distress
Advances in Alzheimer's blood tests are promising earlier diagnosis but triggering significant emotional distress and confusion for patients.
◼ Archived
Health
🔮 fades
New Alzheimer’s drug could stop disease
A new generation of Alzheimer's treatments, including Roche's brainshuttle therapy, may stop the disease before symptoms even appear.
◼ Archived
Business
🔮 fades
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.